A recent article published earlier this month in Frontier in Cellular and Infection Microbiology, recognized R. Jude Samulski, Ph.D., as the most cited and co-cited expert for AAV gene therapy advancements. Here are the details.
A recent article, “Bibliometric analysis of global research trends in adeno-associated virus vector for gene therapy (1991-2022),” published earlier this month in Frontier in Cellular and Infection Microbiology, recognized R. Jude Samulski, Ph.D., as the most cited and co-cited expert for AAV gene therapy advancements.
Helen Keller International Picks New President and CEO philanthropy.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philanthropy.com Daily Mail and Mail on Sunday newspapers.
Exploring the gene therapy biomanufacturing landscape europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.
Gene therapy for ultra-rare diseases afflicting children stand to significantly advance with a ground-breaking launch of Social Purpose Corporation, Elpida Tx.